Tidmarsh will temporarily guide CBER’s regulatory activities while the FDA searches for a permanent department lead.

According to a Department of Health and Human Services spokesperson, he resigned to “spend more time with his family.” ...

From the meme stock revival to Trump's Fed feud, Peter Hodson looks at some of the summer's more bizarre trends ...

In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...

Frazier was among the most active venture investors in 2024, according to analysts at William Blair, backing 17 private life ...

The former official, Vinay Prasad, had been on the job three months and had recently come under attack by conservative ...

Indian-origin scientist Vinay Prasad resigned as the FDA's vaccine and gene therapy chief in just three months after backlash ...

But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...

Gene Therapy Market Gene therapy market surges on breakthroughs in genome editing, rising chronic & genetic disease cases, regulatory appro ...

Donald Trump reportedly ignored calls from Health Secretary Robert F. Kennedy Jr. not to fire the top vaccine official at the Food and Drug Administration after a pressure campaign from far-right ...

The immediate ebullient reaction to Vinay Prasad’s ouster is understandable, and may ultimately be the correct one, Adam ...

The president overruled his HHS secretary and FDA chief, four people with knowledge of the decision tell POLITICO.